Clinical trial
A Phase I, Open-Label Study Evaluating The Pharmacokinetics of Components of S-1 Patients With Impaired Hepatic Function
NCT00398424 is registered in ClinicalTrials.gov with Taiho Oncology, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I, Open-Label Study Evaluating The Pharmacokinetics of Components of S-1 Patients With Impaired Hepatic Function
- Lead sponsor
- Taiho Oncology, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2006
- Completion date
- March 31, 2009
- Enrollment
- 24 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
impaired hepatic function